Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Irinotecan (CPT-11) combined with bolus 5-fluorouracil/leucovorin (Saltz regimen) as first-line chemotherapy of patients with advanced colorectal cancer.
Barceló R, López Vivanco G, Rivera F, GarcíaGirón C, Alonso M, Castañón C, Ramos M, Navalón M, Centelles M, Balcells M. Barceló R, et al. Among authors: balcells m. Anticancer Drugs. 2006 Jan;17(1):89-94. doi: 10.1097/01.cad.0000185181.80227.93. Anticancer Drugs. 2006. PMID: 16317295 Clinical Trial.
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer.
Aranda E, Carrato A, Cervantes A, Sastre J, Gómez MA, Abad A, Masutti B, Ribera F, Marcuello E, Pronk L, Balcells M, Díaz-Rubio E; Grupo Español de Traitamiento de Tumores Digestivos. Aranda E, et al. Among authors: balcells m. Ann Oncol. 2004 Apr;15(4):559-67. doi: 10.1093/annonc/mdh158. Ann Oncol. 2004. PMID: 15033659 Free article. Clinical Trial.
Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU): a phase II study.
Antón A, Aranda E, Carrato A, Marcuello E, Massutti B, Cervantes A, Abad A, Sastre J, Fenández-Martos C, Gallén M, Díaz-Rubio E, Huarte L, Balcells M; TTD cooperative group. Antón A, et al. Among authors: balcells m. Methods Find Exp Clin Pharmacol. 2003 Oct;25(8):639-43. doi: 10.1358/mf.2003.25.8.778085. Methods Find Exp Clin Pharmacol. 2003. PMID: 14671682 Free article. Clinical Trial.
178 results